MS-DRG 951

Principal Diagnosis - Pdx

• Z04.89 Encounter for examination and observation for other specified reasons
• Z04.9 Encounter for examination and observation for unspecified reason
• Z05.0 Observation and evaluation of newborn for suspected cardiac condition ruled out
• Z05.1 Observation and evaluation of newborn for suspected infectious condition ruled out
• Z05.2 Observation and evaluation of newborn for suspected neurological condition ruled out
• Z05.3 Observation and evaluation of newborn for suspected respiratory condition ruled out
• Z05.41 Observation and evaluation of newborn for suspected genetic condition ruled out
• Z05.42 Observation and evaluation of newborn for suspected metabolic condition ruled out
• Z05.43 Observation and evaluation of newborn for suspected immunologic condition ruled out
• Z05.5 Observation and evaluation of newborn for suspected gastrointestinal condition ruled out
• Z05.6 Observation and evaluation of newborn for suspected genitourinary condition ruled out
• Z05.71 Observation and evaluation of newborn for suspected skin and subcutaneous tissue condition ruled out
• Z05.72 Observation and evaluation of newborn for suspected musculoskeletal condition ruled out
• Z05.73 Observation and evaluation of newborn for suspected connective tissue condition ruled out
• Z05.81 Observation and evaluation of newborn for suspected condition related to home physiologic monitoring device ruled out
• Z05.89 Observation and evaluation of newborn for other specified suspected condition ruled out
• Z05.9 Observation and evaluation of newborn for unspecified suspected condition ruled out
• Z09 Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
• Z11.0 Encounter for screening for intestinal infectious diseases
• Z11.1 Encounter for screening for respiratory tuberculosis
• Z11.2 Encounter for screening for other bacterial diseases
• Z11.3 Encounter for screening for infections with a predominantly sexual mode of transmission
• Z11.4 Encounter for screening for human immunodeficiency virus [HIV]
• Z11.51 Encounter for screening for human papillomavirus (HPV)
• Z11.52 Encounter for screening for COVID-19
• Z11.59 Encounter for screening for other viral diseases
• Z11.6 Encounter for screening for other protozoal diseases and helminthiases
• Z11.7 Encounter for testing for latent tuberculosis infection
• Z11.8 Encounter for screening for other infectious and parasitic diseases
• Z11.9 Encounter for screening for infectious and parasitic diseases, unspecified
• Z12.0 Encounter for screening for malignant neoplasm of stomach
• Z12.10 Encounter for screening for malignant neoplasm of intestinal tract, unspecified
• Z12.11 Encounter for screening for malignant neoplasm of colon
• Z12.12 Encounter for screening for malignant neoplasm of rectum
• Z12.13 Encounter for screening for malignant neoplasm of small intestine
• Z12.2 Encounter for screening for malignant neoplasm of respiratory organs
• Z12.31 Encounter for screening mammogram for malignant neoplasm of breast
• Z12.39 Encounter for other screening for malignant neoplasm of breast
• Z12.4 Encounter for screening for malignant neoplasm of cervix
• Z12.5 Encounter for screening for malignant neoplasm of prostate
• Z12.6 Encounter for screening for malignant neoplasm of bladder
• Z12.71 Encounter for screening for malignant neoplasm of testis
• Z12.72 Encounter for screening for malignant neoplasm of vagina
• Z12.73 Encounter for screening for malignant neoplasm of ovary
• Z12.79 Encounter for screening for malignant neoplasm of other genitourinary organs
• Z12.81 Encounter for screening for malignant neoplasm of oral cavity
• Z12.82 Encounter for screening for malignant neoplasm of nervous system
• Z12.83 Encounter for screening for malignant neoplasm of skin
• Z12.89 Encounter for screening for malignant neoplasm of other sites
• Z12.9 Encounter for screening for malignant neoplasm, site unspecified
• Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
• Z13.1 Encounter for screening for diabetes mellitus
• Z13.21 Encounter for screening for nutritional disorder
• Z13.220 Encounter for screening for lipoid disorders
• Z13.228 Encounter for screening for other metabolic disorders
• Z13.29 Encounter for screening for other suspected endocrine disorder
• Z13.30 Encounter for screening examination for mental health and behavioral disorders, unspecified
• Z13.31 Encounter for screening for depression
• Z13.32 Encounter for screening for maternal depression
• Z13.39 Encounter for screening examination for other mental health and behavioral disorders
• Z13.40 Encounter for screening for unspecified developmental delays
• Z13.41 Encounter for autism screening
• Z13.42 Encounter for screening for global developmental delays (milestones)
• Z13.49 Encounter for screening for other developmental delays
• Z13.5 Encounter for screening for eye and ear disorders
• Z13.6 Encounter for screening for cardiovascular disorders
• Z13.71 Encounter for nonprocreative screening for genetic disease carrier status
• Z13.79 Encounter for other screening for genetic and chromosomal anomalies
• Z13.810 Encounter for screening for upper gastrointestinal disorder
• Z13.811 Encounter for screening for lower gastrointestinal disorder
• Z13.818 Encounter for screening for other digestive system disorders
• Z13.820 Encounter for screening for osteoporosis
• Z13.828 Encounter for screening for other musculoskeletal disorder
• Z13.83 Encounter for screening for respiratory disorder NEC
• Z13.84 Encounter for screening for dental disorders
• Z13.850 Encounter for screening for traumatic brain injury
• Z13.858 Encounter for screening for other nervous system disorders
• Z13.88 Encounter for screening for disorder due to exposure to contaminants
• Z13.89 Encounter for screening for other disorder
• Z13.9 Encounter for screening, unspecified
• Z14.01 Asymptomatic hemophilia A carrier
• Z14.02 Symptomatic hemophilia A carrier
• Z14.1 Cystic fibrosis carrier
• Z14.8 Genetic carrier of other disease
• Z15.01 Genetic susceptibility to malignant neoplasm of breast
• Z15.02 Genetic susceptibility to malignant neoplasm of ovary
• Z15.03 Genetic susceptibility to malignant neoplasm of prostate
• Z15.04 Genetic susceptibility to malignant neoplasm of endometrium
• Z15.09 Genetic susceptibility to other malignant neoplasm
• Z15.81 Genetic susceptibility to multiple endocrine neoplasia [MEN]
• Z15.89 Genetic susceptibility to other disease
• Z17.0 Estrogen receptor positive status [ER+]
• Z17.1 Estrogen receptor negative status [ER-]
• Z18.01 Retained depleted uranium fragments
• Z18.09 Other retained radioactive fragments
• Z18.10 Retained metal fragments, unspecified
• Z18.11 Retained magnetic metal fragments
• Z18.12 Retained nonmagnetic metal fragments
• Z18.2 Retained plastic fragments
• Z18.31 Retained animal quills or spines